Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
09 2019
Historique:
received: 28 01 2019
accepted: 02 06 2019
entrez: 22 8 2019
pubmed: 23 8 2019
medline: 21 3 2020
Statut: ppublish

Résumé

There is wide variance among individuals in the fraction of insulin cleared by the liver (20% to 80%). Hepatic insulin clearance is 67% lower in African Americans than European Americans. Clearance is also lower in African American children 7-13 years of age. Lower hepatic insulin clearance will result in peripheral hyperinsulinemia: this exacerbates insulin resistance, which stresses the β-cells, possibly resulting in their ultimate failure and onset of type 2 diabetes. We hypothesize that lower insulin clearance can be a primary cause of type 2 diabetes in at-risk individuals.

Identifiants

pubmed: 31431441
pii: 68/9/1709
doi: 10.2337/db19-0098
pmc: PMC6702636
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1709-1716

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK027619
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK027619
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 by the American Diabetes Association.

Références

Diabetes. 2000 Jun;49(6):992-8
pubmed: 10866052
Diabetes. 2000 Dec;49(12):2094-101
pubmed: 11118012
J Biol Chem. 2002 Jan 11;277(2):1076-84
pubmed: 11694516
Nat Genet. 2002 Mar;30(3):270-6
pubmed: 11850617
Exp Clin Endocrinol Diabetes. 2003 May;111(3):121-4
pubmed: 12784183
Diabetes. 1992 Mar;41(3):368-77
pubmed: 1551497
Diabetes. 2005 Jun;54(6):1649-56
pubmed: 15919785
Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1581-9
pubmed: 17284579
Am J Clin Nutr. 1992 Feb;55(2 Suppl):582S-585S
pubmed: 1733132
Gastroenterology. 2008 Jul;135(1):122-30
pubmed: 18474251
Am J Med. 1991 Jun 24;90(6A):8S-14S
pubmed: 1872310
Endocrinology. 2009 Aug;150(8):3503-12
pubmed: 19406938
Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E941-8
pubmed: 19671837
Diabet Med. 2009 Dec;26(12):1185-92
pubmed: 20002468
Diabetes Care. 2010 Sep;33(9):2098-103
pubmed: 20805282
Obesity (Silver Spring). 2011 Mar;19(3):528-35
pubmed: 20885386
Ann N Y Acad Sci. 2010 Nov;1212:59-77
pubmed: 21091714
Int J Body Compos Res. 2010;8(Supp):77-81
pubmed: 21243097
Hum Genomics. 2011 Jan;5(2):79-89
pubmed: 21296741
Diagn Pathol. 2011 May 11;6:40
pubmed: 21569294
Med Clin North Am. 2011 Sep;95(5):875-92
pubmed: 21855697
Trends Endocrinol Metab. 2012 Mar;23(3):133-41
pubmed: 22245457
Diabetologia. 2012 Aug;55(8):2183-92
pubmed: 22584727
Diabetes Care. 2012 Dec;35(12):2432-7
pubmed: 23173132
Diabetes Care. 2013 Apr;36(4):901-7
pubmed: 23223351
Diabetes Care. 2013 Jun;36(6):1789-96
pubmed: 23704681
PLoS One. 2014 Sep 26;9(9):e108693
pubmed: 25259572
Diabetes Care. 2015 Feb;38(2):213-9
pubmed: 25338926
Endocr Connect. 2015 Mar;4(1):R1-R15
pubmed: 25385852
Int J Obes (Lond). 2015 Dec;39(12):1703-9
pubmed: 26155920
Diabetologia. 2015 Nov;58(11):2663-70
pubmed: 26254577
Am J Physiol Endocrinol Metab. 2015 Oct 15;309(8):E747-58
pubmed: 26306598
Diabetes. 2016 Jun;65(6):1556-64
pubmed: 26993071
Cell Metab. 2016 Jun 14;23(6):1154-1166
pubmed: 27238637
Diabetes. 2017 Oct;66(10):2564-2570
pubmed: 28710139
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E605-E612
pubmed: 29509434
Diabetes. 2018 Aug;67(8):1495-1503
pubmed: 29752425
J Diabetes. 2018 Oct;10(10):778-783
pubmed: 29961982
Diabetes Obes Metab. 2018 Dec;20(12):2869-2875
pubmed: 30019375
Diabetologia. 1985 Feb;28(2):70-5
pubmed: 3884419
J Clin Endocrinol Metab. 1983 Jun;56(6):1294-300
pubmed: 6341392
J Clin Endocrinol Metab. 1980 Sep;51(3):520-8
pubmed: 6997329
Diabetes. 1980 Dec;29(12):979-90
pubmed: 7002673
Am J Med. 1981 Jan;70(1):151-68
pubmed: 7006388
J Clin Invest. 1981 Dec;68(6):1456-67
pubmed: 7033284
Diabetes. 1994 Aug;43(8):1066-84
pubmed: 8039601
Diabetes Care. 1993 Jan;16(1):157-77
pubmed: 8123057
Diabetes. 1993 Nov;42(11):1663-72
pubmed: 8405710
Metabolism. 1993 Oct;42(10):1232-41
pubmed: 8412735
J Clin Invest. 1996 Mar 15;97(6):1497-503
pubmed: 8617883
Mol Cell. 1998 Nov;2(5):559-69
pubmed: 9844629

Auteurs

Richard N Bergman (RN)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA richard.bergman@cshs.org.

Francesca Piccinini (F)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Morvarid Kabir (M)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Cathryn M Kolka (CM)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Marilyn Ader (M)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH